Prevalence of genital psoriasis in patients with psoriasis-Reference-Cited by-同舟云学术

Prevalence of genital psoriasis in patients with psoriasis

Published:2018-03-28 Issue:8 Volume:29 Page:754-760
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Meeuwis Kim A. P.¹,Potts Bleakman Alison²,van de Kerkhof Peter C. M.¹,Dutronc Yves³,Henneges Carsten⁴,Kornberg Lori J.⁵,Menter Alan⁶

Affiliation:

1. Department of Dermatology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands;

2. Eli Lilly and Company, Indianapolis, IN, USA;

3. Lilly France, Neuilly sur Seine, France;

4. Lilly Deutschland GmbH, Bad Homburg, Germany;

5. Syneos Health, Raleigh, NC, USA;

6. Baylor University Medical Center, Dallas, TX, USA

Funder

Eli Lilly and Company

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2018.1453125

Reference21 articles.

1. Genital Psoriasis Awareness Program: Physical and Psychological Care for Patients with Genital Psoriasis

2. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning

3. Genital psoriasis: a questionnaire-based survey on a concealed skin disease in the Netherlands

4. Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study

5. Clinicaltrials.gov [Internet]. A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment; [cited 2017 Jul 24]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT02634801

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and clinical features of psoriasis in hard-to-treat body locations: A Chinese nationwide population-based study;2024-08-17

2. Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24‐week real‐world study;The Journal of Dermatology;2024-08-12

3. Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study;Journal of the European Academy of Dermatology and Venereology;2024-06-26

4. Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis);Dermatology Practical & Conceptual;2024-04-30

5. Sexual dysfunctions in psoriatic patients;Frontiers in Public Health;2024-04-17